TreeWAS – Variant ID: rs8014194

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H52.1 Myopia	0.000	0.910	0.090
Z04.3 Examination and observation following other accident	0.000	0.939	0.061
H52 Disorders of refraction and accommodation	0.000	0.952	0.048
C71.9 Brain, unspecified	0.044	0.956	0.000
C71 Malignant neoplasm of brain	0.041	0.959	0.000
H52.7 Disorder of refraction, unspecified	0.000	0.960	0.040
C71.3 Parietal lobe	0.036	0.964	0.000
C71.1 Frontal lobe	0.035	0.965	0.000
H52.0 Hypermetropia	0.000	0.965	0.035
H52.6 Other disorders of refraction	0.000	0.965	0.035
H52.5 Disorders of accommodation	0.000	0.965	0.035
H01.0 Blepharitis	0.000	0.965	0.035
C71.4 Occipital lobe	0.034	0.966	0.000
C71.8 Overlapping lesion of brain	0.033	0.967	0.000
C71.5 Cerebral ventricle	0.032	0.967	0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.000	0.968	0.032
H52.4 Presbyopia	0.000	0.968	0.031
H52.3 Anisometropia and aniseikonia	0.000	0.969	0.031
C71.7 Brain stem	0.030	0.970	0.000
C71.6 Cerebellum	0.029	0.970	0.000
C71.2 Temporal lobe	0.029	0.971	0.000
H50 Other strabismus	0.000	0.974	0.026
H49 Paralytic strabismus	0.000	0.974	0.026
C71.0 Cerebrum, except lobes and ventricles	0.024	0.976	0.000
H52.2 Astigmatism	0.000	0.976	0.024
H50.1 Divergent concomitant strabismus	0.000	0.976	0.024
E10.3 With ophthalmic complications	0.000	0.977	0.023
O42.9 Premature rupture of membranes, unspecified	0.022	0.978	0.000
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.022	0.978	0.000
H51 Other disorders of binocular movement	0.000	0.978	0.022
H01 Other inflammation of eyelid	0.000	0.979	0.021
H49.0 Third [oculomotor] nerve palsy	0.000	0.979	0.021
H50.0 Convergent concomitant strabismus	0.000	0.979	0.021
H49.2 Sixth [abducent] nerve palsy	0.000	0.980	0.020
H50.2 Vertical strabismus	0.000	0.980	0.020
H50.4 Other and unspecified heterotropia	0.000	0.980	0.020
H50.8 Other specified strabismus	0.000	0.980	0.020
H49.9 Paralytic strabismus, unspecified	0.000	0.980	0.020
O42 Premature rupture of membranes	0.020	0.980	0.000
H49.8 Other paralytic strabismus	0.000	0.981	0.019
H49.4 Progressive external ophthalmoplegia	0.000	0.981	0.019
H49.3 Total (external) ophthalmoplegia	0.000	0.981	0.019
H49.1 Fourth [trochlear] nerve palsy	0.000	0.981	0.019
H50.6 Mechanical strabismus	0.000	0.981	0.019
H50.3 Intermittent heterotropia	0.000	0.981	0.019
E10 Insulin-dependent diabetes mellitus	0.000	0.981	0.019
E10.4 With neurological complications	0.000	0.981	0.019
H01.8 Other specified inflammation of eyelid	0.000	0.982	0.018
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.017	0.983	0.000
E10.5 With peripheral circulatory complications	0.000	0.983	0.017
H51.9 Disorder of binocular movement, unspecified	0.000	0.984	0.016
H51.8 Other specified disorders of binocular movement	0.000	0.984	0.016
H51.1 Convergence insufficiency and excess	0.000	0.984	0.016
H51.0 Palsy of conjugate gaze	0.000	0.984	0.016
H01.1 Non-infectious dermatoses of eyelid	0.000	0.985	0.015
H51.2 Internuclear ophthalmoplegia	0.000	0.985	0.015
H50.5 Heterophoria	0.000	0.986	0.014
E10.8 With unspecified complications	0.000	0.986	0.014
O42.2 Premature rupture of membranes, labour delayed by therapy	0.014	0.986	0.000
E10.0 With coma	0.000	0.986	0.014
H01.9 Inflammation of eyelid, unspecified	0.000	0.986	0.014
E10.7 With multiple complications	0.000	0.986	0.014
C69 Malignant neoplasm of eye and adnexa	0.014	0.986	0.000
H50.9 Strabismus, unspecified	0.000	0.986	0.013
K00.6 Disturbances in tooth eruption	0.000	0.987	0.013
E10.2 With renal complications	0.000	0.987	0.013
E10.6 With other specified complications	0.000	0.987	0.013
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.012	0.988	0.000
C70 Malignant neoplasm of meninges	0.011	0.989	0.000
C69.6 Orbit	0.011	0.989	0.000
C69.3 Choroid	0.011	0.989	0.000
N88.8 Other specified noninflammatory disorders of cervix uteri	0.000	0.989	0.011
E10.9 Without complications	0.000	0.989	0.011
C69.0 Conjunctiva	0.010	0.990	0.000
C69.8 Overlapping lesion of eye and adnexa	0.010	0.990	0.000
C69.5 Lachrymal gland and duct	0.010	0.990	0.000
C69.4 Ciliary body	0.010	0.990	0.000
C69.2 Retina	0.010	0.990	0.000
C69.1 Cornea	0.010	0.990	0.000
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.010	0.990	0.000
E10.1 With ketoacidosis	0.000	0.990	0.010
K74.3 Primary biliary cirrhosis	0.010	0.990	0.000
N36.2 Urethral caruncle	0.000	0.991	0.009
C69.9 Eye, unspecified	0.009	0.991	0.000
C72.9 Central nervous system, unspecified	0.009	0.991	0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.009	0.991	0.000
C72.5 Other and unspecified cranial nerves	0.009	0.991	0.000
C72.4 Acoustic nerve	0.009	0.991	0.000
C72.3 Optic nerve	0.009	0.991	0.000
C72.2 Olfactory nerve	0.009	0.991	0.000
C72.1 Cauda equina	0.009	0.991	0.000
C70.9 Meninges, unspecified	0.008	0.992	0.000
C70.1 Spinal meninges	0.008	0.992	0.000
C72.0 Spinal cord	0.008	0.992	0.000
E11.2 With renal complications	0.000	0.992	0.008
E10-E14 Diabetes mellitus	0.000	0.992	0.008
C70.0 Cerebral meninges	0.007	0.993	0.000
K74 Fibrosis and cirrhosis of liver	0.007	0.993	0.000
N36.0 Urethral fistula	0.000	0.993	0.007
N36 Other disorders of urethra	0.000	0.993	0.007
E11 Non-insulin-dependent diabetes mellitus	0.000	0.993	0.007
L28.0 Lichen simplex chronicus	0.000	0.993	0.007
E11.8 With unspecified complications	0.000	0.993	0.007
K74.1 Hepatic sclerosis	0.007	0.993	0.000
K00 Disorders of tooth development and eruption	0.000	0.993	0.006
G24.9 Dystonia, unspecified	0.000	0.993	0.006
N36.8 Other specified disorders of urethra	0.000	0.994	0.006
K74.0 Hepatic fibrosis	0.006	0.994	0.000
E11.1 With ketoacidosis	0.000	0.994	0.006
E12 Malnutrition-related diabetes mellitus	0.000	0.994	0.006
Z87.2 Personal history of diseases of the skin and subcutaneous tissue	0.000	0.994	0.006
N36.9 Urethral disorder, unspecified	0.000	0.994	0.006
N36.1 Urethral diverticulum	0.000	0.994	0.005
E11.0 With coma	0.000	0.995	0.005
K74.4 Secondary biliary cirrhosis	0.005	0.995	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.005	0.995	0.000
T42.4 Benzodiazepines	0.000	0.995	0.005
K00.0 Anodontia	0.000	0.995	0.005
S32.30 Fracture of ilium (closed)	0.005	0.995	0.000
E11.7 With multiple complications	0.000	0.995	0.005
M85.89 Other specified disorders of bone density and structure (Site unspecified)	0.005	0.995	0.000
E11.6 With other specified complications	0.000	0.995	0.005
K72.9 Hepatic failure, unspecified	0.005	0.995	0.000
K74.5 Biliary cirrhosis, unspecified	0.005	0.995	0.000
E13 Other specified diabetes mellitus	0.000	0.995	0.005
K00.8 Other disorders of tooth development	0.000	0.995	0.005
K00.7 Teething syndrome	0.000	0.995	0.005
K00.5 Hereditary disturbances in tooth structure, not elsewhere classified	0.000	0.995	0.005
K00.4 Disturbances in tooth formation	0.000	0.995	0.005
K00.3 Mottled teeth	0.000	0.995	0.005
K00.2 Abnormalities of size and form of teeth	0.000	0.995	0.005
K00.1 Supernumerary teeth	0.000	0.995	0.005
K00.9 Disorder of tooth development, unspecified	0.000	0.995	0.005
K72 Hepatic failure, not elsewhere classified	0.005	0.995	0.000
M34.9 Systemic sclerosis, unspecified	0.005	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.995	0.005
K72.0 Acute and subacute hepatic failure	0.005	0.995	0.000
K74.6 Other and unspecified cirrhosis of liver	0.005	0.995	0.000
E11.4 With neurological complications	0.000	0.995	0.005
E12.9 Without complications	0.000	0.996	0.004
E12.8 With unspecified complications	0.000	0.996	0.004
E12.7 With multiple complications	0.000	0.996	0.004
E12.6 With other specified complications	0.000	0.996	0.004
E12.5 With peripheral circulatory complications	0.000	0.996	0.004
E12.4 With neurological complications	0.000	0.996	0.004
E12.3 With ophthalmic complications	0.000	0.996	0.004
E12.2 With renal complications	0.000	0.996	0.004
E12.1 With ketoacidosis	0.000	0.996	0.004
E12.0 With coma	0.000	0.996	0.004
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.996	0.004
T42.1 Iminostilbenes	0.000	0.996	0.004
M34 Systemic sclerosis	0.004	0.996	0.000
M34.1 CR(E)ST syndrome	0.004	0.996	0.000
Z04 Examination and observation for other reasons	0.000	0.996	0.004
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.004	0.996	0.000
G24 Dystonia	0.000	0.996	0.004
T42.0 Hydantoin derivatives	0.000	0.996	0.004
H35.3 Degeneration of macula and posterior pole	0.000	0.996	0.004
I45.2 Bifascicular block	0.000	0.996	0.004
E13.8 With unspecified complications	0.000	0.996	0.004
E13.7 With multiple complications	0.000	0.996	0.004
E13.6 With other specified complications	0.000	0.996	0.004
E13.5 With peripheral circulatory complications	0.000	0.996	0.004
E13.4 With neurological complications	0.000	0.996	0.004
E13.3 With ophthalmic complications	0.000	0.996	0.004
E13.2 With renal complications	0.000	0.996	0.004
E13.1 With ketoacidosis	0.000	0.996	0.004
E13.0 With coma	0.000	0.996	0.004
M34.8 Other forms of systemic sclerosis	0.004	0.996	0.000
H34.8 Other retinal vascular occlusions	0.000	0.996	0.004
Z50.0 Cardiac rehabilitation	0.004	0.996	0.000
L28 Lichen simplex chronicus and prurigo	0.000	0.996	0.004
H46 Optic neuritis	0.000	0.996	0.004
H31 Other disorders of choroid	0.000	0.996	0.004
M34.0 Progressive systemic sclerosis	0.004	0.996	0.000
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.000	0.996	0.004
H46-H48 Disorders of optic nerve and visual pathways	0.000	0.996	0.004
Chapter VII Diseases of the eye and adnexa	0.000	0.996	0.004
K72.1 Chronic hepatic failure	0.004	0.996	0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.004	0.996	0.000
S32.3 Fracture of ilium	0.004	0.996	0.000
H31.0 Chorioretinal scars	0.000	0.996	0.004
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.996	0.004
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.996	0.004
T42.3 Barbiturates	0.000	0.996	0.004
T42.2 Succinimides and oxazolidinediones	0.000	0.996	0.004
K70-K77 Diseases of liver	0.004	0.996	0.000
M85.8 Other specified disorders of bone density and structure	0.004	0.996	0.000
H34 Retinal vascular occlusions	0.000	0.996	0.004
H30-H36 Disorders of choroid and retina	0.000	0.996	0.004
K75.4 Autoimmune hepatitis	0.004	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.996	0.004
G24.8 Other dystonia	0.000	0.996	0.003
G24.3 Spasmodic torticollis	0.000	0.996	0.003
I45.6 Preexcitation syndrome	0.000	0.996	0.004
E14 Unspecified diabetes mellitus	0.000	0.996	0.004
K73 Chronic hepatitis, not elsewhere classified	0.004	0.996	0.000
Z39.1 Care and examination of lactating mother	0.003	0.997	0.000
L28.1 Prurigo nodularis	0.000	0.997	0.003
L89.1 Stage II decubitus ulcer	0.000	0.997	0.003
E11.5 With peripheral circulatory complications	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
M85.81 Other specified disorders of bone density and structure (Shoulder region)	0.003	0.997	0.000
H31.8 Other specified disorders of choroid	0.000	0.997	0.003
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.997	0.003
M34.2 Systemic sclerosis induced by drugs and chemicals	0.003	0.997	0.000
Z04.4 Examination and observation following alleged rape and seduction	0.000	0.997	0.003
Z04.2 Examination and observation following work accident	0.000	0.997	0.003
Z04.0 Blood-alcohol and blood-drug test	0.000	0.997	0.003
H35 Other retinal disorders	0.000	0.997	0.003
H35.6 Retinal haemorrhage	0.000	0.997	0.003
G24.4 Idiopathic orofacial dystonia	0.000	0.997	0.003
G24.2 Idiopathic nonfamilial dystonia	0.000	0.997	0.003
G24.1 Idiopathic familial dystonia	0.000	0.997	0.003
G24.0 Drug-induced dystonia	0.000	0.997	0.003
Z04.6 General psychiatric examination, requested by authority	0.000	0.997	0.003
Z04.1 Examination and observation following transport accident	0.000	0.997	0.003
K73.8 Other chronic hepatitis, not elsewhere classified	0.003	0.997	0.000
K83.1 Obstruction of bile duct	0.000	0.997	0.003
E13.9 Without complications	0.000	0.997	0.003
H05.8 Other disorders of orbit	0.000	0.997	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
K73.2 Chronic active hepatitis, not elsewhere classified	0.003	0.997	0.000
M54.12 Radiculopathy (Cervical region)	0.003	0.997	0.000
H31.1 Choroidal degeneration	0.000	0.997	0.003
I45.5 Other specified heart block	0.000	0.997	0.003
S72.20 Subtrochanteric fracture (closed)	0.003	0.997	0.000
Z31.2 In vitro fertilisation	0.003	0.997	0.000
M85.87 Other specified disorders of bone density and structure (Ankle and foot)	0.003	0.997	0.000
Z31 Procreative management	0.003	0.997	0.000
H90.0 Conductive hearing loss, bilateral	0.003	0.997	0.000
H90 Conductive and sensorineural hearing loss	0.003	0.997	0.000
H35.2 Other proliferative retinopathy	0.000	0.997	0.003
K82.4 Cholesterolosis of gallbladder	0.000	0.997	0.003
L28.2 Other prurigo	0.000	0.997	0.003
N36.3 Prolapsed urethral mucosa	0.001	0.997	0.003
H47 Other disorders of optic [2nd] nerve and visual pathways	0.000	0.997	0.003
M85.86 Other specified disorders of bone density and structure (Lower leg)	0.003	0.997	0.000
H31.9 Disorder of choroid, unspecified	0.000	0.997	0.003
H31.4 Choroidal detachment	0.000	0.997	0.003
H31.2 Hereditary choroidal dystrophy	0.000	0.997	0.003
E14.1 With ketoacidosis	0.000	0.997	0.003
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere	0.000	0.997	0.003
K71 Toxic liver disease	0.003	0.997	0.000
H30 Chorioretinal inflammation	0.000	0.997	0.003
M85.88 Other specified disorders of bone density and structure (Other)	0.003	0.997	0.000
M85.80 Other specified disorders of bone density and structure (Multiple sites)	0.003	0.997	0.000
S32.31 Fracture of ilium (open)	0.003	0.997	0.000
E14.8 With unspecified complications	0.000	0.997	0.003
H31.3 Choroidal haemorrhage and rupture	0.000	0.997	0.003
K75 Other inflammatory liver diseases	0.003	0.997	0.000
H34.2 Other retinal artery occlusions	0.000	0.997	0.003
I45 Other conduction disorders	0.000	0.997	0.003
K77 Liver disorders in diseases classified elsewhere	0.003	0.997	0.000
M85.84 Other specified disorders of bone density and structure (Hand)	0.003	0.997	0.000
M85.83 Other specified disorders of bone density and structure (Forearm)	0.003	0.997	0.000
M85.82 Other specified disorders of bone density and structure (Upper arm)	0.003	0.997	0.000
S32.40 Fracture of acetabulum (closed)	0.003	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
H34.0 Transient retinal artery occlusion	0.000	0.997	0.003
H05 Disorders of orbit	0.000	0.997	0.003
H03 Disorders of eyelid in diseases classified elsewhere	0.000	0.997	0.003
H32 Chorioretinal disorders in diseases classified elsewhere	0.000	0.997	0.003
M21.27 Flexion deformity (Ankle and foot)	0.003	0.997	0.000
S32.80 Fracture of other and unspecified parts of lumbar spine and pelvis (closed)	0.003	0.997	0.000
H34.1 Central retinal artery occlusion	0.000	0.997	0.003
E14.7 With multiple complications	0.000	0.997	0.003
E14.6 With other specified complications	0.000	0.997	0.003
E14.2 Withrenal complications	0.000	0.997	0.003
E14.0 With coma	0.000	0.997	0.003
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.003	0.997	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.003	0.997	0.000
Z31.4 Procreative investigation and testing	0.003	0.997	0.000
H90.2 Conductive hearing loss, unspecified	0.003	0.997	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
H59.8 Other postprocedural disorders of eye and adnexa	0.000	0.997	0.003
K73.9 Chronic hepatitis, unspecified	0.003	0.997	0.000
H34.9 Retinal vascular occlusion, unspecified	0.000	0.997	0.003
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
S32.4 Fracture of acetabulum	0.003	0.997	0.000
C45.9 Mesothelioma, unspecified	0.000	0.997	0.003
G57.6 Lesion of plantar nerve	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
H35.1 Retinopathy of prematurity	0.000	0.997	0.003
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.000	0.997	0.003
E14.5 With peripheral circulatory complications	0.000	0.997	0.002
H47.2 Optic atrophy	0.000	0.997	0.003
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.003
E14.4 With neurological complications	0.000	0.997	0.002
G24.5 Blepharospasm	0.000	0.997	0.002
H47.1 Papilloedema, unspecified	0.000	0.997	0.003
H90.3 Sensorineural hearing loss, bilateral	0.003	0.997	0.000
N41.1 Chronic prostatitis	0.000	0.997	0.003
O02.1 Missed abortion	0.003	0.997	0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.002
T46.7 Peripheral vasodilators	0.000	0.997	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.002
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.003	0.997	0.000
S72.10 Pertrochanteric fracture (closed)	0.003	0.997	0.000
E06.3 Autoimmune thyroiditis	0.000	0.997	0.003
S32 Fracture of lumbar spine and pelvis	0.003	0.997	0.000
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.000	0.997	0.002
H43-H45 Disorders of vitreous body and globe	0.000	0.997	0.002
H05.0 Acute inflammation of orbit	0.000	0.997	0.002
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.002	0.997	0.000
Z31.8 Other procreative management	0.002	0.997	0.000
Z31.6 General counselling and advice on procreation	0.002	0.997	0.000
Z31.5 Genetic counselling	0.002	0.997	0.000
Z31.3 Other assisted fertilisation methods	0.002	0.997	0.000
Z31.1 Artifical insemination	0.002	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.002
H30.9 Chorioretinal inflammation, unspecified	0.000	0.998	0.002
Z31.9 Procreative management, unspecified	0.002	0.998	0.000
I45.3 Trifascicular block	0.000	0.998	0.002
M35.3 Polymyalgia rheumatica	0.000	0.998	0.002
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.998	0.002
S01.0 Open wound of scalp	0.000	0.998	0.002
H47.7 Disorder of visual pathways, unspecified	0.000	0.998	0.002
H47.6 Disorders of visual cortex	0.000	0.998	0.002
H47.5 Disorders of other visual pathways	0.000	0.998	0.002
H47.4 Disorders of optic chiasm	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
H47.3 Other disorders of optic disk	0.000	0.998	0.002
H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere	0.000	0.998	0.002
H48.1 Retrobulbar neuritis in diseases classified elsewhere	0.000	0.998	0.002
H48.0 Optic atrophy in diseases classified elsewhere	0.000	0.998	0.002
H90.5 Sensorineural hearing loss, unspecified	0.002	0.998	0.000
K71.9 Toxic liver disease, unspecified	0.002	0.998	0.000
K71.8 Toxic liver disease with other disorders of liver	0.002	0.998	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.002	0.998	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.002	0.998	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.002	0.998	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.002	0.998	0.000
K71.2 Toxic liver disease with acute hepatitis	0.002	0.998	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
M85.85 Other specified disorders of bone density and structure (Pelvic region and thigh)	0.002	0.998	0.000
H30.8 Other chorioretinal inflammations	0.000	0.998	0.002
H30.2 Posterior cyclitis	0.000	0.998	0.002
H30.1 Disseminated chorioretinal inflammation	0.000	0.998	0.002
H30.0 Focal chorioretinal inflammation	0.000	0.998	0.002
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.002	0.998	0.000
I45.4 Nonspecific intraventricular block	0.000	0.998	0.002
K71.0 Toxic liver disease with cholestasis	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.002	0.998	0.000
K75.2 Nonspecific reactive hepatitis	0.002	0.998	0.000
K75.1 Phlebitis of portal vein	0.002	0.998	0.000
H55-H59 Other disorders of eye and adnexa	0.000	0.998	0.002
H10-H13 Disorders of conjunctiva	0.000	0.998	0.002
I45.0 Right fascicular block	0.000	0.998	0.002
K77.8 Liver disorders in other diseases classified elsewhere	0.002	0.998	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
Z04.9 Examination and observation for unspecified reason	0.000	0.998	0.002
H03.8 Involvement of eyelid in other diseases classified elsewhere	0.000	0.998	0.002
H03.0 Parasitic infestation of eyelid in diseases classified elsewhere	0.000	0.998	0.002
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.000	0.998	0.002
H05.3 Deformity of orbit	0.000	0.998	0.002
H05.1 Chronic inflammatory disorders of orbit	0.000	0.998	0.002
N64.9 Disorder of breast, unspecified	0.000	0.998	0.002
E14.3 With ophthalmic complications	0.000	0.998	0.002
H32.8 Other chorioretinal disorders in diseases classified elsewhere	0.000	0.998	0.002
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
H35.0 Background retinopathy and retinal vascular changes	0.000	0.998	0.002
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.000	0.998	0.002
E11.9 Without complications	0.000	0.998	0.002
H72.8 Other perforations of tympanic membrane	0.002	0.998	0.000
G20 Parkinson's disease	0.000	0.998	0.002
H35.5 Hereditary retinal dystrophy	0.000	0.998	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
H03.1 Involvement of eyelid in other infectious diseases classified elsewhere	0.000	0.998	0.002
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.002	0.998	0.000
H36 Retinal disorders in diseases classified elsewhere	0.000	0.998	0.002
S32.41 Fracture of acetabulum (open)	0.002	0.998	0.000
G55.2 Nerve root and plexus compressions in spondylosis	0.002	0.998	0.000
G57.8 Other mononeuropathies of lower limb	0.000	0.998	0.002
Z88.6 Personal history of allergy to analgesic agent	0.000	0.998	0.002
Z29.2 Other prophylactic chemotherapy	0.000	0.998	0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
S32.81 Fracture of other and unspecified parts of lumbar spine and pelvis (open)	0.002	0.998	0.000
F33.9 Recurrent depressive disorder, unspecified	0.000	0.998	0.002
K75.0 Abscess of liver	0.002	0.998	0.000
M21.2 Flexion deformity	0.002	0.998	0.000
Z04.5 Examination and observation following other inflicted injury	0.000	0.998	0.002
I45.8 Other specified conduction disorders	0.000	0.998	0.002
K75.3 Granulomatous hepatitis, not elsewhere classified	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.002	0.998	0.000
H11.9 Disorder of conjunctiva, unspecified	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
H05.9 Disorder of orbit, unspecified	0.000	0.998	0.002
S32.2 Fracture of coccyx	0.002	0.998	0.000
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.000	0.998	0.002
H35.7 Separation of retinal layers	0.000	0.998	0.002
H66.1 Chronic tubotympanic suppurative otitis media	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
Z73.3 Stress, not elsewhere classified	0.000	0.998	0.002
D04.5 Skin of trunk	0.002	0.998	0.000
H35.4 Peripheral retinal degeneration	0.000	0.998	0.002
H73.8 Other specified disorders of tympanic membrane	0.002	0.998	0.000
H72 Perforation of tympanic membrane	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
C45.0 Mesothelioma of pleura	0.000	0.998	0.002
H35.9 Retinal disorder, unspecified	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
M21.26 Flexion deformity (Lower leg)	0.002	0.998	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.000	0.998	0.002
H53-H54 Visual disturbances and blindness	0.000	0.998	0.002
I21.0 Acute transmural myocardial infarction of anterior wall	0.002	0.998	0.000
N99.4 Postprocedural pelvic peritoneal adhesions	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.000	0.998	0.002
H11.1 Conjunctival degenerations and deposits	0.000	0.998	0.002
H59.0 Vitreous syndrome following cataract surgery	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
Z29.0 Isolation	0.000	0.998	0.002
J94.2 Haemothorax	0.000	0.998	0.002
S72.2 Subtrochanteric fracture	0.002	0.998	0.000
G20-G26 Extrapyramidal and movement disorders	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
C45 Mesothelioma	0.000	0.998	0.002
M21.25 Flexion deformity (Pelvic region and thigh)	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
G57.3 Lesion of lateral popliteal nerve	0.000	0.998	0.002
H05.4 Enophthalmos	0.000	0.998	0.002
H06.3 Other disorders of orbit in diseases classified elsewhere	0.000	0.998	0.002
H06.1 Parasitic infestation of orbit in diseases classified elsewhere	0.000	0.998	0.002
H06.0 Disorders of lachrymal system in diseases classified elsewhere	0.000	0.998	0.002
H13 Disorders of conjunctiva in diseases classified elsewhere	0.000	0.998	0.002
S32.5 Fracture of pubis	0.002	0.998	0.000
H11 Other disorders of conjunctiva	0.000	0.998	0.002
H35.8 Other specified retinal disorders	0.000	0.998	0.002
H54.4 Blindness, one eye	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
S32.7 Multiple fractures of lumbar spine and pelvis	0.002	0.998	0.000
S32.1 Fracture of sacrum	0.002	0.998	0.000
H00 Hordeolum and chalazion	0.000	0.998	0.002
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)	0.002	0.998	0.000
E11.3 With ophthalmic complications	0.000	0.998	0.002
H36.8 Other retinal disorders in diseases classified elsewhere	0.000	0.998	0.002
H72.0 Central perforation of tympanic membrane	0.002	0.998	0.000
T45.5 Anticoagulants	0.000	0.998	0.002
H72.9 Perforation of tympanic membrane, unspecified	0.002	0.998	0.000
K75.8 Other specified inflammatory liver diseases	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations